Trace elements and cardiovascular diseases

Journal of Cardiovascular Risk

Volumn 3, Issue 1, 1996, Pages 18-25

  Houtman, Jan P W ^a,b,c  

^a Interuniversity Reactor Institute ^*  (Belgium)

^b Interuniversity Reactor Institute Delft   (Netherlands)

^c DELFT UNIVERSITY OF TECHNOLOGY   (Netherlands)

Author keywords

Cardiovascular diseases; Environment; Hypertension; Public health; Trace elements

Indexed keywords

CHROMIUM; COBALT; COPPER; FLUORINE; MANGANESE; SELENIUM; SILICON; TRACE ELEMENT; VANADIUM; ZINC;

CARDIOVASCULAR DISEASE; ENVIRONMENT; HUMAN; HYPERTENSION; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW;

ANIMALS; CARDIOVASCULAR DISEASES; CLINICAL TRIALS; ENVIRONMENTAL EXPOSURE; HUMANS; INCIDENCE; RISK FACTORS; TRACE ELEMENTS;

EID: 0029899260     PISSN: 13506277     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043798-199602000-00004     Document Type: Review

References (96)

1. ICRP Publication 23, Oxford: Pergamon Press, 1974: 327-328.
2. Masironi R: Trace elements and cardiovascular diseases. Bull WHO 1969, 40:305-312.
3. Masironi R: Trace elements in relation to cardiovascular diseases. Symposium on Nuclear Techniques in the Life Sciences. Vienna: IAEA; 1984:603-516.
4. Mertz W: Trace elements and atherosclerosis. Fed Proc 1982, 41:2807-2812.
5. Esterbauer H, Gebicki J, Puhl H, Jürgens G: The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Rad Biol Med 1993, 13:341-390. Comprehensive review of the role of LDL oxidation in development of CVD, Oxidation mechanisms and role of copper.
6. Maiorino M, Zamburlini A, Roveri A, Ursini F: Prooxidant role of vitamin E in copper induced lipid peroxidation. FEBS Lett 1993, 330:174-176.
7. Coudray C, Charlton V, de Leiris J, Favier A: Effect of zinc deficiency on lipid peroxidation status and infarct size in rat hearts. Int J Cardiology 1993, 41:109-113.
8. Powell SR, Hall D, Aiuto L, Wapnir RA, Teichberg S, Tortolani AJ: Zinc improves postischemic recovery of isolated rat hearts through inhibition of oxidative stress. Am J Physiol 1994, 266:H2497-H2507.
9. Wilkins GM, Leake DS: The oxidation of low density lipoprotein by cells or iron is inhibited by zinc. FEBS Lett 1994, 341:259-262.
10. Hennig B, McClain CJ, Diana JN: Function of vitamin E and zinc in maintaining endothelial integrity. Ann NY Acad Sci 1993, 686:99-109.
11. Oliver M: Cholesterol and coronary disease. Outstanding questions. Cardiovasc Drugs Ther 1992, 6:131-136.
12. Starkebaum G, Harlan JM: Endothelial cell injury due to copper catalyzed hydrogen peroxide generation from homocysteine. J Clin Invest 1986, 77:1370-1376.
13. Swain JA, Darley-Usmar V, Gutteridge JMC: Peroxynitrite releases copper from caeruloplasmin: implications for atherosclerosis. FEBS Lett 1994, 342:49-52.
14. Kuzuya M, Yamada K, Hayashi T, Funaki C, Naito M, Asai K, et al.: Role of lipoprotein-copper complex in copper catalyzed-peroxidation of low-density lipoprotein. Biochem Biophys Acta 1992, 1123:334-341.
15. Chang MC, Lees AM, Lees RS: Low density lipoprotein modification and arterial wall accumulation in a rabbit model of atherosclerosis. Biochemistry 1993, 32:8518-8524.
16. Klevay LM: Ischemic heart disease. A major obstacle to becoming old. Clin Geriatr Med 1987, 3:361-372.
17. Klevay LM: Ischemic heart disease as copper deficiency. Adv Exp Med Biol 1989, 258:197-200.
18. Carness, WH, et al.: Trace Subst Environ Health 1968, 29-39.
19. Coulson, WF: Meth Achievm Exp Pathol 1972, 6:111-138.
20. Harris ED, et al.: Elastin and elastic tissue. New York: Plenum Press, 1977: 543-559.
21. Klevay LM, Viestenz KE: Abnormal electrocardiograms in rats deficient in copper. Am J Physiol 1981, 240:H185-H189.
22. Klevay LM, Halas ES: The effects of dietary copper deficiency and psychological stress on blood pressure in rats. Physiol Behav 1991, 49:309-314.
23. Miller MJ, Murthy L, Basom R, Petering HG: Alteration in hepatocytes after manipulation of the diet: copper, zinc, cadmium interactions. Am J Anat 1975, 141:23-40.
24. Redman RS, Fields M, Reiser S, Smith JC: Dietary fructose exacerbates the cardiac abnormalities of copper deficiency in rats. Atherosclerosis 1988, 74:203-214.
25. Arias IM, Popper H, Schachter D, Shafritz DA: The Liver, Biology and Pathology, New York: Raven Press 1982.
26. Vadlamudi RK, McCormick L, Medeiros DM, Vossaughi J, Failla ML: Copper deficiency alters collagen types and covalent cross-linking in swine myocardium and cardiac valves. J Am Physiol Soc 1993, 264:H2155-H2161.
27. Oster O, Dahm M, Oelert H: Element concentrations (selenium, copper, zinc, iron, magnesium, potassium, phosphorous) in heart tissue of patients with coronary heart disease correlated with physiological parameters of the heart. Eur Heart J 1993, 14:770-774.
28. Kägi JHR, Nordberg M: Metallothionein. Proceedings of the First International Meeting on Metallothionein and other Low Molecular Weight Metal Binding Proteins. Basel: Birkhauser Verlag 1979. Description of the fundamental metallothionein properties.
29. Najda J, Gminski J, Drózdz M, Danch A, Silicon metabolism: The interrelations of inorganic silicon with systemic iron, zinc and copper pools in the rat. Biol Trace Element Res 1992, 34:185-195.
30. Magos L, et al.: CRC Critical Reviews in Toxicology. Boca Raton: CRC Press; 1980: 1-42.
31. Koeman JH, Peeters WHM, Koudstaal-Hol CHM, Tjioe PS, de Goeij JJM: Mercury-selenium correlations in marine mammals. Nature 1973, 245:385-386.
32. Cortes Toro E, de Goey JJM, Bacso J, Cheng Y-D, Kinova L, Matsubara J, et al.: The significance of hair mineral analysis as a means for assessing internal body burdens of environmental pollutants: results from an IAEA coordinated research programme. J Radioanal Nucl Chem 1993, 167:413-421.
33. Aalbers ThG: Cardiovascular Diseases and Trace Elements [Thesis]. Delft: Technological University 1984.
34. Aalbers ThG, Houtman JPW, Makkink B: Trace-element concentrations in human autopsy tissue. Clin Chem 1987, 32:2057-2064.
35. Houtman JPW: Prolonged low-level cadmium intake and atherosclerosis. Sci Total Environ 1993, 138:31-36.
36. Staessen J, Lauwerijs R: Health effects of environmental exposure to cadmium in a population study. J Hum Hypertens 1993, 7:195-199.
37. Aalbers ThG, Houtman JPW: Relationships between trace elements and atherosclerosis. Sci Total Environ 1985, 43:255-283. Most extensive data set available of trace element concentrations in some human organs.
38. Mendis S: Magnesium, zinc and manganese in atherosclerosis of the aorta. Biol Trace Elements Res 1989, 22:251-256.
39. Underwood EJ: Trace Elements in Human and Animal Nutrition, 3rd edn. New York: Academic Press, 1971.
40. Venugopal B, et al.: Metal Toxicity in Mammals. New York: Plenum Press, 1978.
41. Bos AJJ: The Amsterdam proton microbeam, [Thesis]. Free University Amsterdam; 1984:45.
42. Peltomaa M, Mattila K, Wolf J, Hyvönen-Dabek M: Proton-induced X-ray emission analysis of atherosclerotic plaques of the carotid bifurcation. Biol Trace Elements Res 1992, 34:249-255.
43. Cichocki T, Heck D, Jarczyk L, Rokita E, Strzalkowski A, Sych M: Elemental composition of the human atherosclerotic artery wall. Histochemistry 1985, 83:87-92. Description of the unique type of contributions of microbeam PIXE studies in cell-biological research.
44. Tiber AM, Sakhaii M, Joffe D, Ratnaparkhi MV: Relative value of plasma copper, zinc, lipids and lipoproteins as markers for coronary artery disease. Atherosclerosis 1986, 62:105-110.
45. Kinsman GD, Howard AN, Stone DL, Mullins PA: Studies in copper status and atherosclerosis. Biochem Soc Trans 1990, 18:1186-1188.
46. Uza G, Vlaicu R: Serum zinc and copper in patients with atherosclerosis and thromboangiitis obliterans. Biol Trace Elem Res 1989, 20:197-206.
47. Salonen JT, Salonen R, Seppänen K, Kantola M, Suntioinen S, Korpela H: Interactions of serum copper, selenium and low density lipoprotein cholesterol in atherogenesis. BMJ 1991, 302:756-760.
48. Yong W, Wue Q, Guo J, Shuang G, Ya J, Deng H, et al.: Correlation of serum lipids, lipoproteins, lipid peroxide products and metals with coronary heart disease. Chin Med J 1993, 106:167-170.
49. Henzel JH, et al.: Trace Subst Environ Health 1970, 336-335.
50. Hooper PL, Visconti L, Garry PJ, Johnson GE: Zinc lowers high density lipoprotein-cholesterol levels. JAMA 1980, 244:1960-1961.
51. Koo SI, Ramlet JS: Dietary cholesterol decreases the serum level of zinc: further evidence for the positive relationship between serum and high-density lipoproteins. Am J Clin Nutr 1983, 37:918-923.
52. Seghizzi P, D'Adda F, Borleri D, Barbic F, Mosconi G: Cobalt myocardiopathy. A critical review of literature. Sci Total Environ 1994, 150:1-3.
53. Meißner D: Manganese and arteriosclerosis [in German]. Z gesamte inn Med 1986, 41:114-115.
54. Suzuki K, Tatsumi H, Satoh S, Sendra T, Nakata T, Fujii J, et al.: Manganese-superoxide dismutase in endothelial cells: localization and mechanism of induction. Am J Physiol 1993, 265:H1173-H1178.
55. Phylactos AC, Harbige LS, Crawford MA: Essential fatty acids alter the activity of manganese-superoxide dismutase in rat heart. Lipids 1994, 29:111-115.
56. Boscolo P, Carmignani M, Volpe AR, Felaco M, Del Rosso G, Porcelli G, et al.: Renal toxicity and arterial hypertension in rats chronically exposed to vanadate. Occup Environ Med 1994, 51:500-503.
57. Riales R, Albrink MJ: Effect of chromium chloride supplementation on glucose tolerance and serum lipids including high-density lipoprotein of adult men. Am J Clin Nutr 1981, 34:2670-2678.
58. Anderson RA, Polansky MM, Bryden NA, Roginsky EE, Mertz W, Glinsmann W: Chromium supplementation of human subjects: effects on glucose, insulin and lipid variables. Metabolism 1983, 32:894-899.
59. Abraham AS, Brooks BA, Eylath U: Chromium and cholesterol-induced atherosclerosis in rabbits. Ann Nutr Metab 1991, 35:203-207.
60. Wang JS: Effects of Cr(6+)-polluted well water on inhabitant's health [English summary]. Chung Hua Yu Fang I Hsueh Tsa Chih 1990, 24:6-8.
61. Mossop RT: Trivalent chromium in atherosclerosis and diabetes. Centr African J Med 1991, 37:369-374.
62. Yang G, Yin S, Zhou R, Gu L, Liu Y, Liu Y: Studies of safe maximal daily dietary Se-intake in a seleniferous area in China. Part II. J Trace Elements Electrolytes Health Dis 1989, 3:123-130,250.
63. Ji Z: Assay of moniliformin content in household grains from families in patients with Keshan disease [English summary]. Chung Hua I Hsueh Tsa Chih (Taipei) 1991, 71:14-15.
64. Wang AG, Chen XM, Lu WQ: Studies on the effects of low-dose selenium and high-dose cadmium on myocardial injury [English summary]. Chung Hua Yu Fang I Hsueh Tsa Chih 1994, 28:94-96.
65. Shamberger RJ: Selenium in the drinking water and cardiovascular disease. J Environ Pathol Toxicol 1980, 4:305-308.
66. Shamberger RJ, et al.: Trace Subst Environ Health 1975, 15-22.
67. Vinceti M, Rovesti S, Marchesi C, Bergomi M, Vivoli G: Changes in drinking water selenium and mortality for coronary disease in a residential cohort. Biol Trace Elements Res 1994, 40:267-275.
68. Oster O, Prellwitz W: Selenium and cardiovascular disease. Biol Trace Elements Res 1990, 24:91-103.
69. Neve J: Sélénium et pathologie cardiovasculaire [Selenium and cardiovascular pathology] [English summary]. Pathol Biol Paris 1989, 37:1102-1106.
70. Schaffer-Kronberger E, Eber B, Wawschinek O, Dusleag J, Friehs I, Gogg R, et al.: Serum selenium levels in distinct manifestations of coronary artery disease. Acta Med Austriaca 1990, 17:22-24.
71. Jossa F, Trevisan M, Krogh V, Farinaro E, Giumetti D, Fusco G, et al.: Serum selenium and coronary heart disease risk factors in southern Italian men. Atherosclerosis 1991, 87:129-134.
72. Wójcicki J, Rózewicka L, Barsew-Wiszniewska B, Samochowiec L, Juzwiak S, Kadlubowska D, et al.: Effect of selenium and vitamin E on the development of experimental atherosclerosis in rabbits. Atherosclerosis 1991, 87:9-16.
73. Raij L, Nagy J, Coffee K, DeMaster G: Hypercholesterolemia promotes endothelial dysfunction in vitamin E- and selenium-deficient rats. Hypertension 1993, 22:56-61.
74. van Vleet JF, Ferrans VJ: Etiologic factors and pathologic alterations in selenium-vitamin E deficiency and excess in animals and humans. Biol Trace Elements Res 1992, 33:1-21.
75. Strambi M, Paciotti F, Longini M, Dettori M: Selenium and hypertension: preliminary data. J Hum Hypertens 1994, 8:397.
76. Lu X, Liu S-Y, Man RYK: Enhancement of endothelium dependent relaxation in the rat aortic ring by selenium supplement. Cardiovasc Res 1994, 28:345-348.
77. Hampel G, Watanabe K, Weksler BB, Jaffe EA: Selenium deficiency inhibits prostacyclin release and enhances production of platelet activating factor by human endothelial cells. Biochim Biophys Acta 1989, 1006:151-158.
78. Girelli D, Olivieri O, Stanzial AM, Azzini M, Lupo A, Bernich P, et al.: Low platelet glutathion peroxidase activity and serum selenium concentration in patients with chronic renal failure: relations to dialysis treatments, diet and cardiovascular complications. Clin Sci 1993, 84:611-617.
79. Wu M-M, Kuo T-L, Hwang Y-H, Chen C-J: Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. Am J Epidemiol 1989, 130:1123-1132.
80. Lin SM, Yang MH: Arsenic, selenium, and zinc in patients with Blackfoot disease. Biol Trace Elem Res 1988, 15:213-221.
81. Engel RR, Smith AH: Arsenic in drinking water and mortality from vascular disease: an ecologic analysis in 30 counties in the United States. Arch Environ Health 1994, 49:418-426.
82. Kaji T, Mishima A, Koyanagi E, Yamamoto C, Sakamoto M, Kozuka H: Possible mechanism for zinc protection against cadmium cytotoxicity in cultured vascular endothelial cells. Toxicology 1992, 76:257-270.
83. Morselt AFW: Environmental pollutants and diseases [Spec Iss]. Toxicology 1991, 70:1-132. Excellent review of the possible contributions of cell-biological and histochemical studies in trace element physiology.
84. Subramanyam G, Bhaskar M, Govindappa S: The role of cadmium in induction of atherosclerosis in rabbits. Indian Heart J 1992, 44:177-180.
85. Voors AW, Johnson WD, Schumann MS: Additive statistical effects of cadmium and lead on heart related diseases in a North Carolina autopsy series. Arch Environ Health 1982, 37:98-102.
86. Whittemore AS, DiCiccio Y, Provenzano G: Urinary cadmium and blood pressure; results from the NHANES II survey. Environ Health Perspect 1991, 91:133-140.
87. Dowd TL, Gupta RK: 19F-NMR study of the effect of lead on intracellular free calcium in human platelets. Biochim Biophys Acta 1991, 1092:341-346.
88. Nolan CV, Shaikh ZA: Lead nephrotoxicity and associated disorders: biochemical mechanisms. Toxicology 1992, 73:127-146.
89. Kopp SJ, Barron JT, Tow JP: Cardiovascular actions of lead and relationship to hypertension: a review. Environ Health Perspect 1988, 78:91-99.
90. Apostoli P, Maranelli G, Micciolo R: Is hypertension a confounding factor in the assessment of blood lead reference values? Sci Total Environ 1992, 120:127-134.
91. Micciolo R, Canal L, Maranelli G, Apostoli P: Non-occupational lead exposure and hypertension in northern Italy. Int J Epidemiol 1994, 23:312-320.
92. Moller LF, Kristensen TS: Lead, a possible risk factor of increased blood pressure and cardiovascular disease [English summary]. Ugeskr Laeger 1993, 155:3203-3207.
93. Staessen J, Dolenc P, Amery A, Buchet JP, Claeys F, Fagard R, et al.: Environmental lead exposure does not increase blood pressure in the population: evidence from the Cadmibel study. J Hypertens 1993, 11:S35-S41.
94. Staessen JA, Bulpitt CJ, Fagard R, Lauwerijs RR, Roels H, Thijs L, et al.: Hypertension caused by low-level lead exposure: myth or fact? J Cardiovasc Risk 1994, 1:87-97.
95. Skoczynska A, Smolik R, Jelen M: Lipid abnormalities in rats given small doses of lead. Arch Toxicol 1993, 67:200-204.
96. Michaels D, Zoloth ZR, Stern FB: Does low-level lead exposure increase risk of death? A mortality study of newspaper printers. Int J Epidemiol 1991, 20:978-983.